Union Health Minister Dr. Harsh Vardhan has said that the central government is considering that those who are most vulnerable to corona should be given the corona vaccine in emergency if needed. Dr. Harsh Vardhan has given this statement on Sunday in Sunday conversation program. During the dialogue, a person named Santosh Kumar told the Health Minister that those who are most at risk from Corona should be allowed to use the vaccine in emergency.
Phase III vaccine trial takes 6-9 months
On this, Health Minister Harsh Vardhan said that, the Government of India is considering it. The Health Minister said that if there is agreement in the government then the people who are most at risk, especially health workers, people working in high risk places, senior citizens or, people who have weak immunity can be allowed to use the vaccine in emergency. The Health Minister said that in general, the Phase III vaccine trial takes 6-9 months, but if the government agrees, it may be decided to reduce the time limit for emergency use of the vaccine. However, the use of emergency will be allowed only after looking at all the safety aspects of the vaccine.
Results of the vaccine trial will be available by the first quarter of 2021
On Sunday, during the Sunday conversation program on whether the vaccine will be safe, the Health Minister said that once the vaccine is available, they will not hold back from using it on their own to reassure people. The Health Minister said that it is expected that the results of the vaccine trial will be available by the first quarter of 2021. Efforts are also being made to produce the vaccine simultaneously so that it does not waste time after the vaccine is developed.
The Health Minister also informed that at present there is more work on 3 vaccines in India and the vaccine that India Biotech and the National Institute of Virology are making is currently in the most advanced stage. The corona vaccine that Bharat Biotech is preparing is named Covaxin and its Phase III trial has started.
Like and Follow us on :